Intracrine modulation of gene expression by intracellular generation of active glucocorticoids

Steroids

Volumn 71, Issue 11-12, 2006, Pages 1001-1006

  Fruchter, Oren ^a,b   Zoumakis, Emmanouil ^a   Alesci, Salvatore ^a   De Martino, Massimo ^a   Chrousos, George ^a   Hochberg, Zeev ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Gene expression; Glucocorticoids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTISONE; GLUCOCORTICOID; PREDNISONE;

ARTICLE; CELL LEVEL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PLASMID; REGULATORY MECHANISM; REPORTER GENE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANTI-ULCER AGENTS; CARBENOXOLONE; CELL LINE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33750007869     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.08.002     Document Type: Article

References (34)

1. Lazar M.A. Mechanism of action of hormones that act as transcription-regulatory factors. In: Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S., and Philadelphia P.A. (Eds). Williams' textbook of endocrinology. 10th ed. (2003), W.B. Saunders Co. 45-64
2. Carson-Jurica M.A., Schrader W.T., and O'Malley B.W. Steroid receptor family: structure and functions. Endocr Rev 11 (1990) 201-220
3. Bamberger C.M., Schulte H.M., and Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17 (1996) 245-261
4. Rabbitt E.H., Lavery G.G., Walker E.A., Cooper M.S., Stewart P.M., and Hewison M. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a el determinant of cell proliferation. Federation Am Soc Exp Biol J 16 (2002) 36-44
5. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25 (2004) 831-866
6. Tomlinson J.W., and Stewart P.M. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Best Practice Res Clin Endocrinol Metab 15 (2001) 61-78
7. Seckl J.R., and Walker B.R. Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
8. Sandeep T.C., and Walker B.R. Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases. Trends Endocrinol Metab 12 (2001) 446-453
9. Feinstein M.B., and Schleimer R.P. The role of 11beta-hydroxysteroid dehydrogenase in regulating glucocorticoid action. In: Goulding N.J., and Flower R.J. (Eds). Milestones in drug therapy (2001), Birkhauser Verlag, Basel, Switzerland 147-160
10. Albiston A.L., Obeyesekere V.R., Smith R.E., and Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105 (1994) R11-R17
11. Maser E., Volker B., and Friebertshauser J. 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. Biochemistry 19 41 (2002) 2459-2465
12. Jamieson P.M., Chapman K.E., Edwards C.R., and Seckl J.R. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
13. Jenkins J.S., and Sampson P.A. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 22 2 (1967) 205-207
14. Labrie F. Intracrinology. Mol Cell Endocrinol 78 (1991) C113-C118
15. Bader T., Zoumakis E., Friedberg M., Chrousos G.P., and Hochberg Z. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes. Hormone Metab Res 34 (2002) 752-757
16. Bujalska I., Shimojo M., Howie A., and Stewart P.M. Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62 (1997) 77-82
17. Wang L., Sun J., Li L., Mears D., Horvat M., and Sheil A.G. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. Cell Transplant 7 (1998) 459-468
18. Diederich S., Hanke B., Burkhardt P., Muller M., Schoneshofer M., Bahr V., and Oelkers W. Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man. Steroids 63 (1998) 271-277
19. Tiosano D., Eisenstein I., Militianu D., Chrousos G.P., and Hochberg Z. 11β-Hydroxysteroid dehydrogenase activity in hypothalamic obesity. J Clin Endocrinol Metab 88 (2003) 379-384
20. Bujalska I.J., Ku S., Hewison M., and Stewart P.M. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 140 (1999) 3188-3196
21. Stewart P.M. Cortisol, hypertension and obesity: the role of 11 beta-hydroxysteroid dehydrogenase. J Roy College Phys London 32 (1998) 154-159
22. Yang K., Khalil M.W., Strutt B.J., and Killinger D.W. 11 Beta-hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol 60 (1997) 247-253
23. Bujalska I.J., Ku S., and Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum"?. Lancet 349 (1997) 1210-1213
24. Andrews R.C., Herlihy O., Livingstone D.E., Andrew R., and Walker B.R. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab 87 (2002) 5587-5593
25. Frey F.J. Kinetics and dynamics of prednisolone. Endocr Rev 8 (1987) 453-473
26. Frey B.M., and Frey F.J. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinetics 19 (1990) 126-146
27. Mendelson C.R. Mechanism of hormone action. In: Griffin J.E., and Ojeda S.R. (Eds). Textbook of endocrine physiology. 4th ed. (2000), Oxford university press, New York 51-88
28. Kenakin T.P. Agonist affinity. In: Kenakin T.P. (Ed). Pharmacologic analysis of drug-receptor interaction. 2nd ed. (1993), Raven Press, New York 1-38
29. Kenakin T.P. The quantification of relative efficacy of agonists. J Pharmacol Toxicol Methods 13 (1985) 281-308
30. Low S.C., Chapman K.E., Edwards C.R., and Seckl J.R. 'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. J Mol Endocrinol 13 (1994) 167-174
31. Warriar N., Page N., and Govindan M.V. Transcription activation of mouse mammary tumor virus-chloramphenicol acetyltransferase: a model to study the metabolism of cortisol. Biochemistry 33 (1994) 12837-12843
32. Livingstone D.E., and Walker B.R. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese zucker rats. J Pharmacol Exp Ther 305 (2003) 167-172
33. Walker B.R., Connacher A.A., Lindsay R.M., Webb D.J., and Edwards C.R. Carbenoxolone increases hepatic insulin sensitivity in man: a el role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80 (1995) 3155-3159
34. Andrews R.C., Rooyackers O., and Walker B.R. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 88 (2003) 285